期刊文献+

PU-VEGF-siRNA对裸鼠皮下舌癌移植瘤生长的影响

In vivo studies on the role of pU-VEGF-siRNA in the growth of tongue cancer xenograft
原文传递
导出
摘要 目的:探讨针对血管内皮生长因子(VEGF)的小干扰RNA(siRNA)对舌癌Tca8113细胞移植瘤在裸鼠体内生长的影响。方法:将两对特异性针对VEGF的siRNA真核表达载体(PU-VEGF-siRNA1,PU-VEGF-siRNA2),经脂质体转染人舌癌TCA8113细胞,经G418筛选后获得稳定表达,以空载体组做实验对照,以未转染舌癌细胞作空白对照。将各组细胞接种裸鼠背部皮下,每组5只,观察裸鼠肿瘤生长情况,免疫组织化学染色法观察裸鼠肿瘤组织VEGF的表达。结果:与实验对照组和空白对照组相比,实验组肿瘤生长速度明显减缓,VEGF表达降低(P<0.05)。结论:siRNA抑制VEGF的表达,可显著抑制舌癌移植瘤在裸鼠体内的生长。 Objective: To assess influence of vector-based small interfering RNA (siRNA) targeting vascular endothelial growth factor (VEGF) for human tongue squamous cell carcinoma (Tca8113) xenografts in vivo. Method: Two vector-based siRNA targeting VEGF (PU-VEGF-siRNA1, PU-VEGF-siRNA2), and eukaryotic expression vector (experiment control) were transfected into Tca8113 ceils by lipofectamine2000, and screened with G418. Non-transfected cell was used as negative control. Twenty nude-mice were divided into 4 groups randomly, and then the transfected cells and non-transfected cell were subcutaneous injected on the back of mice, respectively. The tumor volume, weight, and growth curve of every group were compared. The protein expression of VEGF was detected by immunohistochemical technique. Result: Compared with experiment and negative controls, the growth of xeograft was significantly reduced, VEGF expression decreased in two experiment groups (P 〈 0.05). But there were no statistically difference of those between two controls (P 〉 0.05). Conclusion: Vector-based siRNA targeting VEGF are efficient in suppressing the growth of Tca8113 cell xenografts in vivo.
出处 《临床口腔医学杂志》 2009年第12期720-722,共3页 Journal of Clinical Stomatology
基金 国家自然科学基金资助(30360111)
关键词 RNA干扰 血管内皮生长因子 舌癌 移植瘤 small interfering RNA (siRNA) vascular endothelial growth factor (VEGF) tongue cancer: xenograft
  • 相关文献

参考文献11

  • 1Folkman J. Clinical applications of research on angiogenesis[J]. N Engl J M, 1995, 333 (26) : 1757-1763.
  • 2Shih CH, Ozawa S,Ando N, et al. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus [J]. Clinical Cancer Res, 2000,6 (3) : 1161-1168.
  • 3Arora S, Kaur J, Sharma C, et al. Stromelysin 3, Ets- 1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density,progression,and prognosis [J]. Clin Cancer Res, 2005, 11 (6) : 2272-2284.
  • 4Tse GM,Chan AW,Yu KH,et al. Strong pression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma [J]. Ann Surg Oncol, 2007, 14 (12) : 3558-3565.
  • 5于大海,曹莹,姚志文,李敬,陈海波,郝洁.载体携带小干扰RNA抑制Tca8113细胞血管内皮生长因子的表达[J].华西口腔医学杂志,2008,26(5):550-552. 被引量:4
  • 6陶娟,涂亚庭,林云,沈关心.pU-VEGF-siRNA对裸鼠恶性黑素瘤生长影响的研究[J].中华皮肤科杂志,2006,39(3):153-156. 被引量:3
  • 7Guan H, Zhou ZC, Wang H,et al. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model[J]. Clin Cancer Res, 2005, 11 (7) : 2662- 2269.
  • 8Matsumoto G, Kushibiki T, Kinoshita Y, et al. Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma [J]. Cancer Sci, 2006, 97 (4) : 313-321.
  • 9Niola F, Evangelisti C,Campagnolo L, et al. A plasmid-encoded VEGF siRNA reduces gliblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model [J]. Cancer Biol Ther, 2006, 5 (2) : 174-179.
  • 10Mulkeeu AL, Silva T, Yoo PS,et al. Short interfering RNA-mediate gene silencing of vascular endothelial growth factor: effects on cellular proliferation in colon cancer cells[J]. Arch Surg, 2006, 141 (4) : 367-374.

二级参考文献15

  • 1陶娟,涂亚庭.恶性黑素瘤内皮型一氧化氮合酶和血管内皮生长因子的表达[J].中华皮肤科杂志,2004,37(10):575-577. 被引量:10
  • 2涂亚庭,陶娟,黄长征,张杏平,张丽霞,沈关心.血管内皮生长因子-siRNA对恶性黑素瘤细胞生长的抑制作用[J].中华皮肤科杂志,2005,38(5):306-308. 被引量:6
  • 3Castro-Rivera E, Ran S, Thorpe P, et al. Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect[J]. Proe Natl Aead Sci U S A, 2004, 101 (31) : 11432-11437.
  • 4Filleur S, Courtin A, Ait-Si-Ali S, et al. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth[J]. Cancer Res, 2003, 63(14):3919- 3922.
  • 5Schiffelers RM, Ansari A, Xu J, et al. Cancer siRNA therapy by tumor selective delivery with hgand-targeted sterically stabilized nanoparticle[J]. Nucleic Acids Res, 2004, 32(19):E149.
  • 6Takei Y, Kadomatsu K, Yuzawa Y, et al. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics[J]. Cancer Res, 2004, 64(10):3365-3370.
  • 7Kwon HS, Shin HC, Kim JS. Suppression of vascular endothelial growth factor expression at the transcriptional and post-transcriptional levels[J]. Nucleic Acids Res, 2005, 33 (8):E74.
  • 8Zhang L, Yang N, Mohamed-Hadley A, et al. Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer[J]. Biochem Biophys Res Commun, 2003, 303(4) : 1169-1178.
  • 9Filleur S,Courtin A,Ait-Si-Ali S,et al.SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.Cancer Res.2003,63:3919-3922.
  • 10Wang ES,Teruya-Feldstein J,Wu Y,et al.Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo.Blood,2004,104:2893-2902.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部